Green Thumb Industries Inc. Annual Report - A Deep Dive for Investors

Green Thumb Industries (GTI) delivered a strong performance in the past fiscal year, navigating a dynamic cannabis market with robust revenue growth and an expanded operational presence. The company generated approximately $1.1 billion in total revenue, an impressive 18% increase year-over-year. This growth stemmed from both expanding retail operations and strong consumer packaged goods (CPG) sales. Despite ongoing industry challenges, GTI achieved a net income of $78 million, a significant turnaround from the prior year's slight loss, reflecting enhanced operational efficiencies and strategic market positioning. Adjusted EBITDA reached $310 million, underscoring healthy core profitability.

Here's a closer look at what matters for your investment decision:

Business Overview

GTI operates primarily through two key segments:

• Retail: This segment, featuring brands like Rise and Cookies, generated $770 million in revenue, a 15% increase, and contributed approximately 70% of total sales. GTI expanded its retail footprint, ending the year with 85 operational dispensaries across 15 states, up from 75 in the previous year. This expansion strategically targeted high-growth, limited-license markets.
• Consumer Packaged Goods (CPG): This segment, home to popular brands such as Rythm, Dogwalkers, and incredibles, saw its revenue climb 25% to $330 million. Growth was driven by new product introductions, increased market penetration, and strong demand for premium cannabis products.
• Intersegment Eliminations and Corporate: This segment manages internal transactions between the retail and CPG divisions and handles overall corporate overhead. It ensures accurate financial reporting by eliminating intercompany sales and expenses between segments.

GTI maintains a broad and strategically diversified presence across 15 states, including key markets like Illinois, Pennsylvania, Florida, and New Jersey. The company's strategy focuses on expansion in limited-license states, where regulatory barriers offer a more protected competitive landscape. Recent acquisitions, such as the integration of Dharma Pharmaceuticals in Virginia, bolstered GTI's market share and cultivation capabilities in emerging East Coast markets. Partnerships, like the one with Agrify Corporation for cultivation technology, enhance production efficiency and product quality.

Financial Performance Highlights

GTI's financial results demonstrate significant progress and operational strength:

• Total Revenue: Approximately $1.1 billion, an 18% increase year-over-year, driven by both retail and CPG segments.
• Net Income: $78 million, a notable improvement from the prior year's loss, reflecting enhanced operational efficiencies.
• Adjusted EBITDA: $310 million, indicating healthy core profitability.
• Retail Segment Revenue: Grew 15% to $770 million.
• CPG Segment Revenue: Increased 25% to $330 million.
• Gross Profit Margin: Maintained a strong 52%.
• Selling, General, and Administrative (SG&A) Expenses: Increased 12% to $350 million in absolute terms but decreased as a percentage of revenue, demonstrating improved operating leverage.

Financial Health

GTI strengthened its financial position during the fiscal year:

• Cash Flow: GTI generated $165 million in operating cash flow, which significantly funded capital expenditures of $90 million (primarily for new dispensary build-outs and cultivation upgrades) and debt reduction.
• Balance Sheet: GTI held $130 million in cash and equivalents and $420 million in total debt, including mortgage notes and credit facilities. The debt-to-equity ratio improved to 0.7x, indicating a healthier financial position. Retained Earnings grew to $210 million, reflecting accumulated profits reinvested in the business.
• Assets: Key assets include Property, Plant, and Equipment totaling $650 million, and valuable Licenses and Permits totaling $280 million, essential for operating in regulated cannabis markets.

Management Discussion and Analysis (MD&A) Highlights

Management's discussion and analysis highlights the key factors influencing GTI's financial condition and results. Expanding retail operations and strong CPG sales primarily drove robust revenue growth and strengthened the company's operational footprint. The notable improvement in net income reflects enhanced operational efficiencies and strategic market positioning. GTI maintained a strong 52% gross profit margin, indicating effective production cost management. Although selling, general, and administrative (SG&A) expenses increased in absolute terms due to expansion and marketing investments, they decreased as a percentage of revenue, demonstrating improved operating leverage. Significant operating cash flow provided internal funding for capital expenditures and debt reduction, contributing to a healthier financial position, as evidenced by an improved debt-to-equity ratio.

Competitive Position

The cannabis market remains highly competitive, with numerous multi-state operators and local businesses vying for market share. Green Thumb Industries differentiates itself and strengthens its competitive standing by focusing its strategy on expansion in limited-license states, where regulatory barriers offer a more protected competitive landscape. Recent strategic acquisitions, such as Dharma Pharmaceuticals, instrumentally bolstered the company's market share and cultivation capabilities in emerging East Coast markets. GTI's ongoing strategic focus aims to achieve sustainable profitability and market leadership within these key regulated states.

Risk Factors

Investors should be aware of several key risks:

• Regulatory Uncertainty: The federal illegality of cannabis in the U.S. poses significant challenges, including limited access to traditional banking services and the punitive IRS Code Section 280E, which disallows standard business deductions for cannabis companies, resulting in higher effective tax rates.
• Intense Competition: The cannabis market is highly competitive, with numerous multi-state operators and local businesses vying for market share.
• Pending Litigation: The company faces various legal proceedings, including intellectual property disputes and routine tax audits by Federal and State Tax Authorities, potentially resulting in significant financial liabilities or operational disruptions.
• Market Volatility: The cannabis sector experiences high volatility due to regulatory news, market sentiment, and evolving consumer preferences.
• Dependence on State-Level Legalization: GTI's operations depend entirely on the continued legality and expansion of cannabis programs at the state level, subject to political changes or voter initiatives.
• Product Liability and Safety Concerns: As a producer and seller of cannabis products, the company faces risks from product quality, safety, and potential liability claims, potentially harming its reputation and financial performance.

Future Outlook

Looking ahead, GTI aims to further optimize its existing operations, expand its retail footprint to over 100 dispensaries in the next fiscal year, and continue innovating its CPG product lines. The company's strategic focus is to achieve sustainable profitability and market leadership in key regulated states, while closely monitoring federal legislative developments that could significantly affect the industry. Management anticipates continued investment in cultivation and processing capabilities to meet growing consumer demand and enhance product quality.

Share Structure & Investor Control

GTI's share structure is unique and important for investors to understand. It includes Multiple Voting Shares and Super Voting Shares owned by founders and key insiders, carrying disproportionately higher voting rights compared to the Subordinate Voting Shares (the common stock traded by retail investors). This structure means that although retail investors own a significant economic interest, a small group of shareholders retains control over major corporate decisions.